Stock Events

Stock Events

Search...

Global X Genomics & Biotechnology

M$210

23

+M$0+0% Friday 19:47

Statistics

Day High

210

Day Low

210

52W High

220

52W Low

169

Volume

275

Avg. Volume

621

Mkt Cap

-

P/E Ratio

-

Dividend Yield

-

Dividend

-

Dividends

0%Dividend Yield

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

N/A

1Y Growth

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GNOM.MX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

ARK Genomic Revolution

ARK Genomic Revolution ETF focuses on companies likely to benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, genomics, and molecular diagnostics, making it a direct competitor in the genomics investment space.

iShares Genomics Immunology and Healthcare

iShares Genomics Immunology and Healthcare ETF aims to track an index composed of developed and emerging market companies that could gain from long-term growth and innovation in genomics, immunology, and bioengineering, closely aligning with GNOM's focus on biotechnology and genomics.

VanEck Vectors Biotech ETF invests in companies involved in the development, production, and marketing of pharmaceuticals, including genomics and biotechnology, positioning it as a competitor to GNOM by targeting a similar sector.

First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund is focused on companies engaged in the research, development, manufacturing, and distribution of various biotechnological products, therapies, and services, including genomics, making it a competitor.

iShares Biotechnology

iShares Biotechnology ETF offers exposure to U.S. biotechnology and pharmaceutical companies, which includes firms involved in genomics and genetic analysis, making it a competitor to GNOM in the biotech investment space.

SPDR S&P Biotech ETF provides exposure to the biotech sector of the S&P, which includes companies involved in the innovation and development of new treatments and technologies in genomics, competing with GNOM's investment focus.

Invesco Biotechnology & Genome

Invesco Dynamic Biotechnology & Genome ETF is focused on companies that are principally engaged in the research, development, manufacturing, and marketing of products based on genetic analysis and genetic engineering, making it a direct competitor to GNOM.

ALPS Medical Breakthroughs

ALPS Medical Breakthroughs ETF invests in the healthcare sector, including small- and mid-cap biotechnology and pharmaceutical companies that have one or more drugs in Phase II or Phase III FDA clinical trials, indirectly competing with GNOM by focusing on innovative healthcare solutions.

About

The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.

Show more...

CEO

Country

US

ISIN

US37954Y4347

Listings